NUWE Nuwellis, Inc.
Healthcare$0.91-13.61%ClosedMarket Cap: $818,807
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.76
P/S
0.11
EV/EBITDA
0.07
DCF Value
$-0.60
FCF Yield
-1214.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.5%
Operating Margin
-141.5%
Net Margin
-214.9%
ROE
-17015.8%
ROA
-263.0%
ROIC
-335.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.4M | 70.1% | $-4.4M | $-4.3M | $— | — |
| Q4 null | $2.4M | 68.2% | $-2.4M | $-2.4M | $— | — |
| FY null | $8.3M | 62.0% | $-11.1M | $-17.5M | $— | — |
| Q3 null | $2.2M | 65.2% | $-2.7M | $468.0K | $— | — |
| Q2 null | $1.7M | 55.5% | $-2.9M | $-12.6M | $— | — |
| Q1 null | $1.9M | 56.0% | $-3.1M | $-3.0M | $— | — |
| Q4 null | $2.3M | 64.8% | $-2.4M | $-1.5M | $— | — |
| FY null | $8.7M | 66.7% | $-11.0M | $-11.2M | $— | — |
| Q3 null | $2.4M | 70.0% | $-1.5M | $2.4M | $— | — |
| Q2 null | $2.2M | 67.2% | $-2.3M | $-7.7M | $— | — |
| Q1 null | $1.9M | 64.1% | $-4.7M | $-4.3M | $— | — |
| Q4 2023 | $2.6M | 54.4% | $-3.6M | $-5.5M | $-54.48 | — |